We offer customized IL-15 molecule design (including Fc-fusion, IL-15Rα super-agonist complexes, and selective pro-cytokines) with optimized codon usage to facilitate high expression in selected microbial or mammalian systems.
Creative Biolabs offers comprehensive solutions from rational molecular design to large-scale production. We provide custom engineering of IL-15 molecules, including highly potent super-agonists and targeted pro-cytokines with improved pharmacokinetics (PK) via Fc-fusion and complex stabilization. Clients gain a development advantage by receiving high-purity, structurally validated, and scalable bio-better IL-15 candidates, leading to reduced material generation timelines and accelerated progression toward advanced research phases.
IL-15 is a potent, non-redundant cytokine crucial for the survival and cytotoxic function of NK and CD8+ T cells, essential effectors in anti-tumor immunity. Its distinct mechanism, which avoids stimulating Treg cells and activation-induced cell death (AICD) seen with IL-2, makes it uniquely superior for cancer immunotherapy. However, the native molecule's half-life is critically short. Creative Biolabs provides validated engineering to overcome this PK challenge, transforming this fundamental cytokine into a clinically viable, targeted therapeutic.
For project feasibility assessment, request a consultation.
Fig.1 IL-15 and its therapeutic applications. 1
We offer customized IL-15 molecule design (including Fc-fusion, IL-15Rα super-agonist complexes, and selective pro-cytokines) with optimized codon usage to facilitate high expression in selected microbial or mammalian systems.
Benefit from our seamless one-stop fermentation service that scales from laboratory proof-of-concept to large-scale production, utilizing industrial fermentation tanks with a total capability exceeding 100,000 liters.
Efficient upstream and downstream process development allows the fermentation process to run in batch, fed-batch, or continuous modes, with optimized culture conditions and the integration of quality-by-design (QbD) principles to maximize bio-better IL-15 yield and purity.
We ensure the stability of strains in cell banks and large-scale fermentations, with high-standard quality control tools used to quantify and evaluate product quality, guaranteeing the consistent structural integrity and purity required for advanced development.
Focuses on fusing the IL-15 molecule to a long-acting carrier, typically an Fc domain of IgG, to leverage FcRn recycling, dramatically extending the serum half-life and reducing required dosing frequency in models.
Designs and produces a stabilized, non-covalent or covalent complex of IL-15 and the IL-15Rα sushi domain, mimicking the potent native trans-presentation mechanism for a superior super-agonist effect.
Utilizes targeted mutagenesis (e.g., within the Rβ binding site) to finely tune the receptor affinity. This strategy increases the functional index by reducing high-affinity binding to off-target cells and minimizing non-specific systemic effects.
Integrates a tumor-specific targeting moiety (e.g., an antibody fragment or peptide) or a tumor-microenvironment (TME) cleavable linker to create pro-cytokines that are only activated in situ, minimizing non-specific peripheral activity.
Focuses on creating specialized IL-15 fusions designed for enhanced ex vivo expansion and in vivo persistence support of adoptive cell transfer (ACT) products, such as CAR T and CAR NK cells, often targeting the IL-15-AKT-XBP1s pathway for superior survival.
| Key Advantages | Unique Features |
|---|---|
| Treg-Sparing Expertise | We specialize in IL-15 mutein design that selectively targets the IL-2Rβ/γ chains, critically reducing the activation of immunosuppressive Treg cells and preserving the anti-tumor immune environment. |
| Proprietary Computational Modeling | Our advanced computational modeling and disulfide scanning protocols accelerate the identification of optimally stabilized IL-15/IL-15Rα superagonist complexes. |
| Validated Cell Armoring | We are experts in generating IL-15-Armored CAR T cells that co-express mbIL15 to achieve autocrine/paracrine stimulation, resulting in superior in vivo T cell memory and persistence. |
To fully understand the Creative Biolabs value proposition: inquiry and formal quotation.
A Our IL-15 variants, particularly those from the lymphocyte-targeted delivery service, are specifically optimized for ACT manufacturing. Their enhanced stability and potency make them superior to standard cytokines for maximizing the yield and functional persistence of CAR T and CAR NK cells, ensuring robust starting material for advanced research.
A We tackle this through our potency modulation and tumor-targeted services. By using precise mutagenesis, we can tune receptor affinity to avoid overstimulation, and by designing pro-cytokines that only release IL-15 in a specific microenvironment, we minimize chronic peripheral exposure that leads to reduced cellular response.
For general high-quality, large-scale production of other cytokines, growth factors, or related proteins needed for your preclinical platform.
Learn More →Provides comprehensive services for scFv optimization, CAR design, and gene synthesis, directly enabling the preparation of CAR NK cells before IL-15 expansion protocols.
Learn More →Creative Biolabs is committed to accelerating the development of superior IL-15 molecules. Our expertise in rational design, Fc-fusion, and complex stabilization ensures your molecule moves from concept to advanced research with maximum potency and stability. To learn more about how our services can accelerate your research, please contact us.
Reference